
June 2 (Reuters) - ATAI Life Sciences NV 9VC.DE:
ATAI LIFE SCIENCES AND BECKLEY PSYTECH TO COMBINE CREATING A GLOBAL LEADER IN PSYCHEDELIC MENTAL HEALTH THERAPIES
ATAI LIFE SCIENCES NV - COMBINED COMPANY TO OPERATE AS ATAI BECKLEY
ATAI LIFE SCIENCES NV - DEAL VALUES BECKLEY AT ABOUT $390 MILLION
ATAI LIFE SCIENCES NV - PHASE 2B STUDY DATA FOR BPL-003 EXPECTED MID-2025
ATAI LIFE SCIENCES NV - BECKLEY ALSO INTENDS TO DISTRIBUTE ELEUSIS HOLDINGS LIMITED AND ITS SUBSIDIARIES
ATAI LIFE SCIENCES NV - CONCURRENT $30 MILLION PRIVATE PLACEMENT BY FERRING VENTURES AND ADAGE CAPITAL